A&D Pharma, the biggest pharmaceutical company on thedomestic market, stepped into the black in 2009, when it posted 19million euros in net profit after two loss-making years. Theturnover was up 3% to 514 million euros. The pharmaceutical marketin Romania shrank by 1.5% to 1.92 billion euros.
The net profit was the result of steps taken to make the localoperations efficient and of the enforcement of a restructuringprogramme that generated 6 million euros in savings, the companyofficials say.
At the same time, A&D Pharma announced the completion of thetakeover of
Ozone Laboratories' operations in Poland, Czech Republic,Hungary, Slovenia and Bulgaria in a deal put at 20-23 millioneuros.
The list of 2010-2011 development goals of A&D Pharma alsoincludes growth by greenfield investments of its newest business -the medical service division Anima, with the company specifying ithad an untapped indebtedness capacity of 60 million euros.
Pentru alte știri, analize, articole și informații din business în timp real urmărește Ziarul Financiar pe WhatsApp Channels
